What question did this study set out to answer?

To assess the feasibility, safety, and clinical benefits of prolonged mechanical circulatory support with the Impella 5.5 device as a bridge to heart transplantation.

August 10, 2022ASAIO Journal

Impella 5.5 Support Beyond 50 Days as Bridge to Heart Transplant in End-Stage Heart Failure Patients

View Full Paper

Ask AI

Bookmark

To assess the feasibility, safety, and clinical benefits of prolonged mechanical circulatory support with the Impella 5.5 device as a bridge to heart transplantation.
Case series evaluating 4 patients with severe left ventricular dysfunction and cardiogenic shock bridged to heart transplantation.
Patients received trans-valvular Impella 5.5 support and were monitored for hemodynamic stability, end-organ perfusion, bleeding, and physical ambulation.
All 4 patients achieved successful bridging to heart transplantation with a mean Impella 5.5 support duration of 70 days (maximum duration: 83 days).
The minimally invasive approach reduced procedural bleeding, accelerated recovery, and facilitated early ambulation to prevent physical deconditioning before transplant surgery.
The device consistently unloaded the left ventricle and sustained adequate hemodynamic support to preserve end-organ function throughout prolonged bridging.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Case series demonstrates prolonged Impella 5.5 bridge to heart transplant in end-stage heart failure, suggesting a feasible alternative to surgical mechanical support.

Cite This Study

Zaky et al. (2022) studied this question.

synapsesocial.com/papers/6a9eabc23a41fb039a11f202 https://doi.org/10.1097/mat.0000000000001796

View Full Paper

Ask AI

Bookmark

Implication

Case series demonstrates prolonged Impella 5.5 bridge to heart transplant in end-stage heart failure, suggesting a feasible alternative to surgical mechanical support.

Impella 5.5 Support Beyond 50 Days as Bridge to Heart Transplant in End-Stage Heart Failure Patients

Key Points

Discussion

Implication

Cite This Study

Impella 5.5 Support Beyond 50 Days as Bridge to Heart Transplant in End-Stage Heart Failure Patients

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider